$BCRX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOCRYST PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in BIOCRYST PHARMACEUTICALS INC. Get notifications about new insider transactions in BIOCRYST PHARMACEUTICALS INC for free.
Page: < prev 1 2 3 4 5 6 ... 9 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 08 2019 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 8.81 | 7,500 | 66,075 | 132,676 | 140.2 K to 132.7 K (-5.35 %) |
| Apr 08 2019 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 5.51 | 7,500 | 41,325 | 140,176 | 132.7 K to 140.2 K (+5.65 %) |
| Mar 14 2019 | BCRX | BIOCRYST PHARMACEU ... | ASELAGE STEVE | Director | Buy | P | 8.30 | 2,000 | 16,600 | 2,000 | 0 to 2 K |
| Feb 04 2019 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Option Exercise | M | 1.20 | 12,188 | 14,626 | 0 | |
| Feb 04 2019 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Option Exercise | M | 1.20 | 19,686 | 23,623 | 0 | |
| Feb 04 2019 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Payment of Exercise | F | 8.68 | 1,685 | 14,626 | 130,587 | 132.3 K to 130.6 K (-1.27 %) |
| Feb 04 2019 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Buy | M | 1.20 | 12,188 | 14,626 | 132,272 | 120.1 K to 132.3 K (+10.15 %) |
| Feb 04 2019 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Payment of Exercise | F | 8.68 | 7,702 | 66,853 | 120,084 | 127.8 K to 120.1 K (-6.03 %) |
| Feb 04 2019 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Buy | M | 1.20 | 19,686 | 23,623 | 127,786 | 108.1 K to 127.8 K (+18.21 %) |
| Jan 30 2019 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 5.45 | 5,000 | 27,250 | 7,000 | |
| Jan 30 2019 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 9.85 | 5,000 | 49,250 | 128,426 | 133.4 K to 128.4 K (-3.75 %) |
| Jan 30 2019 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 5.45 | 5,000 | 27,250 | 133,426 | 128.4 K to 133.4 K (+3.89 %) |
| Jan 29 2019 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | M | 3.22 | 2,000 | 6,440 | 79,427 | |
| Jan 29 2019 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | M | 3.22 | 4,000 | 12,880 | 81,427 | |
| Jan 29 2019 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | M | 3.22 | 6,000 | 19,320 | 85,427 | |
| Jan 29 2019 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 9.91 | 2,000 | 19,820 | 0 | 2 K to 0 (-100.00 %) |
| Jan 29 2019 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Buy | M | 3.22 | 2,000 | 6,440 | 2,000 | 0 to 2 K |
| Jan 29 2019 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 9.88 | 4,000 | 39,520 | 0 | 4 K to 0 (-100.00 %) |
| Jan 29 2019 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Buy | M | 3.22 | 4,000 | 12,880 | 4,000 | 0 to 4 K |
| Jan 29 2019 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 9.60 | 6,000 | 57,600 | 0 | 6 K to 0 (-100.00 %) |
| Jan 29 2019 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Buy | M | 3.22 | 6,000 | 19,320 | 6,000 | 0 to 6 K |
| Jan 23 2019 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | M | 3.22 | 2,000 | 6,440 | 91,427 | |
| Jan 23 2019 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 9.40 | 2,000 | 18,800 | 0 | 2 K to 0 (-100.00 %) |
| Jan 23 2019 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Buy | M | 3.22 | 2,000 | 6,440 | 2,000 | 0 to 2 K |
| Jan 18 2019 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | M | 3.22 | 3,046 | 9,808 | 93,427 | |
| Jan 18 2019 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 9.27 | 3,046 | 28,236 | 0 | 3 K to 0 (-100.00 %) |
| Jan 18 2019 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Buy | M | 3.22 | 3,046 | 9,808 | 3,046 | 0 to 3 K |
| Jan 16 2019 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | M | 3.22 | 954 | 3,072 | 96,473 | |
| Jan 16 2019 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 9.20 | 954 | 8,777 | 0 | 954 to 0 (-100.00 %) |
| Jan 16 2019 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Buy | M | 3.22 | 954 | 3,072 | 954 | 0 to 954 |
| Jan 08 2019 | BCRX | BIOCRYST PHARMACEU ... | ASELAGE STEVE | Director | Option Exercise | A | 8.62 | 25,000 | 215,500 | 25,000 | |
| Jan 03 2019 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Payment of Exercise | F | 8.07 | 771 | 6,222 | 108,100 | 108.9 K to 108.1 K (-0.71 %) |
| Jan 03 2019 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Payment of Exercise | F | 8.07 | 785 | 6,335 | 132,676 | 133.5 K to 132.7 K (-0.59 %) |
| Jan 03 2019 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Payment of Exercise | F | 8.07 | 3,568 | 28,794 | 724,106 | 727.7 K to 724.1 K (-0.49 %) |
| Dec 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | Senior VP, Chief Le ... | Option Exercise | A | 7.06 | 190,000 | 1,341,400 | 190,000 | |
| Dec 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | A | 7.06 | 190,000 | 1,341,400 | 190,000 | |
| Dec 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Option Exercise | A | 7.06 | 235,000 | 1,659,100 | 235,000 | |
| Dec 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Option Exercise | A | 7.06 | 335,000 | 2,365,100 | 335,000 | |
| Dec 21 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | A | 7.06 | 235,000 | 1,659,100 | 235,000 | |
| Dec 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Option Exercise | A | 7.06 | 675,000 | 4,765,500 | 675,000 | |
| Dec 20 2018 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Sell | S | 7.58 | 20,488 | 155,299 | 2,725 | 23.2 K to 2.7 K (-88.26 %) |
| Dec 12 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | M | 3.22 | 2,000 | 6,440 | 97,427 | |
| Dec 12 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | M | 3.22 | 2,000 | 6,440 | 99,427 | |
| Dec 12 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 9.11 | 2,000 | 18,220 | 0 | 2 K to 0 (-100.00 %) |
| Dec 12 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Buy | M | 3.22 | 2,000 | 6,440 | 2,000 | 0 to 2 K |
| Dec 12 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 9.01 | 2,000 | 18,020 | 0 | 2 K to 0 (-100.00 %) |
| Dec 12 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Buy | M | 3.22 | 2,000 | 6,440 | 2,000 | 0 to 2 K |
| Dec 06 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 9.45 | 3,922 | 37,063 | 133,461 | 137.4 K to 133.5 K (-2.85 %) |
| Dec 06 2018 | BCRX | BIOCRYST PHARMACEU ... | HEGGIE THERESA | Director | Option Exercise | A | 9.27 | 30,000 | 278,100 | 30,000 | |
| Dec 04 2018 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | Senior VP, Chief Le ... | Option Exercise | M | 1.42 | 25,000 | 35,500 | 25,000 | |
| Dec 04 2018 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | Senior VP, Chief Le ... | Sell | S | 9.07 | 44,290 | 401,710 | 77,953 | 122.2 K to 78 K (-36.23 %) |
| Dec 04 2018 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | Senior VP, Chief Le ... | Buy | M | 1.42 | 25,000 | 35,500 | 122,243 | 97.2 K to 122.2 K (+25.71 %) |
| Nov 30 2018 | BCRX | BIOCRYST PHARMACEU ... | Erck Stanley C | Director | Option Exercise | M | 1.49 | 8,333 | 12,416 | 0 | |
| Nov 30 2018 | BCRX | BIOCRYST PHARMACEU ... | Erck Stanley C | Director | Buy | M | 1.49 | 8,333 | 12,416 | 48,333 | 40 K to 48.3 K (+20.83 %) |
| Nov 26 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | M | 3.22 | 12,000 | 38,640 | 101,427 | |
| Nov 26 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 9.01 | 2,455 | 22,120 | 0 | 2.5 K to 0 (-100.00 %) |
| Nov 26 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 9.06 | 12,000 | 108,720 | 2,455 | 14.5 K to 2.5 K (-83.02 %) |
| Nov 26 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Buy | M | 3.22 | 12,000 | 38,640 | 14,455 | 2.5 K to 14.5 K (+488.80 %) |
| Nov 26 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.78 | 3,500 | 13,230 | 28,305 | |
| Nov 26 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.78 | 7,000 | 26,460 | 31,805 | |
| Nov 26 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 5.45 | 5,000 | 27,250 | 12,000 | |
| Nov 26 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 9.66 | 3,500 | 33,810 | 137,383 | 140.9 K to 137.4 K (-2.48 %) |
| Nov 26 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 3.78 | 3,500 | 13,230 | 140,883 | 137.4 K to 140.9 K (+2.55 %) |
| Nov 26 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 9.08 | 7,000 | 63,560 | 137,383 | 144.4 K to 137.4 K (-4.85 %) |
| Nov 26 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 3.78 | 7,000 | 26,460 | 144,383 | 137.4 K to 144.4 K (+5.10 %) |
| Nov 26 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 9.41 | 5,000 | 47,050 | 137,383 | 142.4 K to 137.4 K (-3.51 %) |
| Nov 26 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 5.45 | 5,000 | 27,250 | 142,383 | 137.4 K to 142.4 K (+3.64 %) |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | M | 3.22 | 9,127 | 29,389 | 113,427 | |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | M | 3.22 | 9,127 | 29,389 | 113,427 | |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | M | 3.22 | 193 | 621 | 122,554 | |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | M | 3.22 | 193 | 621 | 122,554 | |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 8.61 | 6,150 | 52,952 | 2,455 | 8.6 K to 2.5 K (-71.47 %) |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 8.61 | 6,150 | 52,952 | 2,455 | 8.6 K to 2.5 K (-71.47 %) |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 8.52 | 9,127 | 77,762 | 8,605 | 17.7 K to 8.6 K (-51.47 %) |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 8.52 | 9,127 | 77,762 | 8,605 | 17.7 K to 8.6 K (-51.47 %) |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Buy | M | 3.22 | 9,127 | 29,389 | 17,732 | 8.6 K to 17.7 K (+106.07 %) |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Buy | M | 3.22 | 9,127 | 29,389 | 17,732 | 8.6 K to 17.7 K (+106.07 %) |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 8.30 | 193 | 1,602 | 8,605 | 8.8 K to 8.6 K (-2.19 %) |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 8.30 | 193 | 1,602 | 8,605 | 8.8 K to 8.6 K (-2.19 %) |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Buy | M | 3.22 | 193 | 621 | 8,798 | 8.6 K to 8.8 K (+2.24 %) |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Buy | M | 3.22 | 193 | 621 | 8,798 | 8.6 K to 8.8 K (+2.24 %) |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.22 | 6,500 | 20,930 | 97,071 | |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.22 | 6,500 | 20,930 | 97,071 | |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.78 | 4,623 | 17,475 | 38,805 | |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.78 | 4,623 | 17,475 | 38,805 | |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.78 | 75 | 284 | 43,428 | |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.78 | 75 | 284 | 43,428 | |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 8.75 | 6,500 | 56,875 | 137,383 | 143.9 K to 137.4 K (-4.52 %) |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 8.75 | 6,500 | 56,875 | 137,383 | 143.9 K to 137.4 K (-4.52 %) |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 3.22 | 6,500 | 20,930 | 143,883 | 137.4 K to 143.9 K (+4.73 %) |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 3.22 | 6,500 | 20,930 | 143,883 | 137.4 K to 143.9 K (+4.73 %) |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 8.57 | 4,623 | 39,619 | 137,383 | 142 K to 137.4 K (-3.26 %) |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 8.57 | 4,623 | 39,619 | 137,383 | 142 K to 137.4 K (-3.26 %) |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 3.78 | 4,623 | 17,475 | 142,006 | 137.4 K to 142 K (+3.37 %) |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 3.78 | 4,623 | 17,475 | 142,006 | 137.4 K to 142 K (+3.37 %) |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 8.30 | 75 | 623 | 137,383 | 137.5 K to 137.4 K (-0.05 %) |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 8.30 | 75 | 623 | 137,383 | 137.5 K to 137.4 K (-0.05 %) |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 3.78 | 75 | 284 | 137,458 | 137.4 K to 137.5 K (+0.05 %) |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 3.78 | 75 | 284 | 137,458 | 137.4 K to 137.5 K (+0.05 %) |
| Nov 09 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.78 | 2,302 | 8,702 | 43,503 | |
| Nov 09 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.22 | 11,113 | 35,784 | 103,571 | |
| Nov 09 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.22 | 672 | 2,164 | 114,684 | |
| Nov 09 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 8.30 | 2,302 | 19,107 | 137,383 | 139.7 K to 137.4 K (-1.65 %) |
| Nov 09 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 3.78 | 2,302 | 8,702 | 139,685 | 137.4 K to 139.7 K (+1.68 %) |
| Nov 09 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 8.09 | 11,113 | 89,904 | 137,383 | 148.5 K to 137.4 K (-7.48 %) |
| Nov 09 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 3.22 | 11,113 | 35,784 | 148,496 | 137.4 K to 148.5 K (+8.09 %) |
| Nov 09 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 8.00 | 672 | 5,376 | 137,383 | 138.1 K to 137.4 K (-0.49 %) |
| Nov 09 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 3.22 | 672 | 2,164 | 138,055 | 137.4 K to 138.1 K (+0.49 %) |
| Nov 09 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | M | 3.22 | 5,280 | 17,002 | 122,747 | |
| Nov 09 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | M | 3.22 | 300 | 966 | 128,027 | |
| Nov 09 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 8.15 | 5,280 | 43,032 | 8,605 | 13.9 K to 8.6 K (-38.03 %) |
| Nov 09 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Buy | M | 3.22 | 5,280 | 17,002 | 13,885 | 8.6 K to 13.9 K (+61.36 %) |
| Nov 09 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 8.00 | 300 | 2,400 | 8,605 | 8.9 K to 8.6 K (-3.37 %) |
| Nov 09 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Buy | M | 3.22 | 300 | 966 | 8,905 | 8.6 K to 8.9 K (+3.49 %) |
| Nov 07 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | M | 3.22 | 100 | 322 | 128,327 | |
| Nov 07 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 8.00 | 100 | 800 | 8,605 | 8.7 K to 8.6 K (-1.15 %) |
| Nov 07 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Buy | M | 3.22 | 100 | 322 | 8,705 | 8.6 K to 8.7 K (+1.16 %) |
| Nov 07 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.22 | 215 | 692 | 115,356 | |
| Nov 07 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 8.00 | 215 | 1,720 | 137,383 | 137.6 K to 137.4 K (-0.16 %) |
| Nov 07 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 3.22 | 215 | 692 | 137,598 | 137.4 K to 137.6 K (+0.16 %) |
| Nov 06 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | M | 3.22 | 1,000 | 3,220 | 128,427 | |
| Nov 06 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 8.00 | 1,000 | 8,000 | 8,605 | 9.6 K to 8.6 K (-10.41 %) |
| Nov 06 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Buy | M | 3.22 | 1,000 | 3,220 | 9,605 | 8.6 K to 9.6 K (+11.62 %) |
| Nov 06 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.78 | 3,500 | 13,230 | 45,805 | |
| Nov 06 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.22 | 7,356 | 23,686 | 115,571 | |
| Nov 06 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 7.96 | 3,500 | 27,860 | 137,383 | 140.9 K to 137.4 K (-2.48 %) |
| Nov 06 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 3.78 | 3,500 | 13,230 | 140,883 | 137.4 K to 140.9 K (+2.55 %) |
| Nov 06 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 7.78 | 7,356 | 57,230 | 137,383 | 144.7 K to 137.4 K (-5.08 %) |
| Nov 06 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 3.22 | 7,356 | 23,686 | 144,739 | 137.4 K to 144.7 K (+5.35 %) |
| Nov 05 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 7.51 | 1,544 | 11,595 | 8,605 | 10.1 K to 8.6 K (-15.21 %) |
| Oct 23 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.78 | 3,150 | 11,907 | 49,305 | |
| Oct 23 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 7.45 | 3,150 | 23,468 | 137,383 | 140.5 K to 137.4 K (-2.24 %) |
| Oct 23 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 3.78 | 3,150 | 11,907 | 140,533 | 137.4 K to 140.5 K (+2.29 %) |
| Oct 23 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 7.50 | 100 | 750 | 10,149 | 10.2 K to 10.1 K (-0.98 %) |
| Oct 04 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.78 | 100 | 378 | 52,455 | |
| Oct 04 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.22 | 972 | 3,130 | 122,927 | |
| Oct 04 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.22 | 5,528 | 17,800 | 123,899 | |
| Oct 04 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.78 | 3,250 | 12,285 | 52,555 | |
| Oct 04 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 7.45 | 100 | 745 | 137,383 | 137.5 K to 137.4 K (-0.07 %) |
| Oct 04 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 3.78 | 100 | 378 | 137,483 | 137.4 K to 137.5 K (+0.07 %) |
| Oct 04 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 7.26 | 972 | 7,057 | 137,383 | 138.4 K to 137.4 K (-0.70 %) |
| Oct 04 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 3.22 | 972 | 3,130 | 138,355 | 137.4 K to 138.4 K (+0.71 %) |
| Oct 04 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 7.27 | 5,528 | 40,189 | 137,383 | 142.9 K to 137.4 K (-3.87 %) |
| Oct 04 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 3.22 | 5,528 | 17,800 | 142,911 | 137.4 K to 142.9 K (+4.02 %) |
| Oct 04 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 7.19 | 3,250 | 23,368 | 137,383 | 140.6 K to 137.4 K (-2.31 %) |
| Oct 04 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 3.78 | 3,250 | 12,285 | 140,633 | 137.4 K to 140.6 K (+2.37 %) |
| Aug 13 2018 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Option Exercise | M | 1.42 | 62,500 | 88,750 | 0 | |
| Aug 13 2018 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Sell | S | 7.03 | 62,500 | 439,375 | 23,213 | 85.7 K to 23.2 K (-72.92 %) |
| Aug 13 2018 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Buy | M | 1.42 | 62,500 | 88,750 | 85,713 | 23.2 K to 85.7 K (+269.25 %) |
| Jun 22 2018 | BCRX | BIOCRYST PHARMACEU ... | LEE KENNETH B JR | Director | Option Exercise | A | 6.09 | 30,000 | 182,700 | 30,000 |